PLYMOUTH, NH – Sanctuary ATC has received a registration certificate to begin operations at its Plymouth dispensary location. With the certificate, Sanctuary ATC will be first alternative treatment center in New Hampshire to begin dispensing therapeutic cannabis to qualifying patients and designated caregivers registered with the ATC when the dispensary opens on Saturday, April 30.
“When the Therapeutic Cannabis Program was established by the Legislature,
it envisioned that people in New Hampshire suffering from serious medical
conditions would be able to access therapeutic cannabis for relief. I am
very pleased to announce that with the opening of the Sanctuary dispensary
in Plymouth, that day has arrived,” said DHHS Commissioner Jeffrey A.
Meyers. “My thanks to the Therapeutic Cannabis Program staff and Sanctuary
ATC for their tireless efforts in realizing this significant achievement on
behalf of patients and caregivers.”
DHHS is implementing the Therapeutic Cannabis Program, which will include four dispensary locations. Temescal Wellness, Inc., which has received a conditional registration certificate and is cultivating therapeutic cannabis, will open its dispensaries in Dover and Lebanon in the next few weeks. Prime ATC, which is completing construction of its cultivation center, expects to open its dispensary in Merrimack later this summer.
Qualifying conditions in NH include:
- Cancer
- Glaucoma
- HIV (Positive Status)
- Acquired Immune Deficiency Syndrome
- Hepatitis C (antiviral treatment)
- ALS
- Muscular Dystrophy
- Crohn’s Disease
- Alzheimer’s Disease
- Epilepsy
- Lupus
- Parkinson’s Disease
- Multiple Sclerosis
- Chronic Pancreatitis
- Spinal Cord Injury or Disease
- Traumatic Brain Injury
- One or more injuries that significantly interfere with daily activities as documented by the patient’s provider
AND a severely debilitating or terminal medical condition or its treatment that has produced at least one of the following:
- Elevated Intraocular Pressure
- Cachexia
- Chemotherapy-Induced Anorexia
- Wasting Syndrome
- Agitation of Alzheimer’s Disease
- Severe Pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasm
Applications for potentially qualifying patients and designated caregivers,
medical provider certification, and other important information can be
found on the Therapeutic Cannabis Program page on the DHHS website.
